Page 83 - JCTR-11-5
P. 83
Journal of Clinical and
Translational Research Fibromyalgia: Examination across life domains
doi: 10.33448/rsd-v11i4.27704 of predominant neuropathic, nociceptive and central
sensitization pain. Acta Oncol. 2016;55(6):659-663.
29. Ramos F, Hora A, Souza C. Contributions of social
epidemiology to clinical research on infectious diseases. doi: 10.3109/0284186X.2016.1167958
Pan-Amazonian Journal of Health. 2016;7:221-229.
41. Macfarlane G, Kronisch C, Dean L, et al. EULAR revised
doi: 10.5123/s2176-62232016000500025 recommendations for the management of fibromyalgia. Ann
Rheum Dis. 2017;76(2):318-328.
30. Souza HR, Providello M, Faustini RK, Silva VF, Abreu J.
Epidemiological profile of women with Fibromyalgia in the doi: 10.1136/annrheumdis-2016-209724
far north of Espírito Santo. Rev CEREUS. 2023;15(4):13-24
42. Clauw D, D’Arcy Y, Gebke K, Semel D, Pauer L, Jones KD.
31. Zimmer Z, Chayovan N, Lin H, Natividad J. How indicators Normalizing fibromyalgia as a chronic illness. Postgrad Med.
of socioeconomic status relate to physical functioning 2018;130(1):9-18.
of older adults in three Asian Societies. Res Aging.
2004;26(2):224-258. doi: 10.1080/00325481.2018.1411743
43. Edwards RR, Dworkin RH, Sullivan MD, Turk DC,
doi: 10.1177/0164027503260624
Wasan AD. The role of psychosocial processes in the
32. Gaskin DJ, Richard P. The economic costs of pain in the development and maintenance of chronic pain. J Pain.
United States. J Pain. 2012;13(8):715-724. 2016;17(9):T70-T92.
doi: 10.1016/j.jpain.2012.03.009 doi: 10.1016/j.jpain.2016.01.001
33. Alberti F, Blatt C, Pilger D. Direct and indirect costs 44. Arnold L, Bennett R, Crofford LJ, et al. AAPT diagnostic
of fibromyalgia: a scoping review. J Bras Econ Saúde. criteria for fibromyalgia. J Pain. 2019;20(6):611-628.
2021;13(3):338-344.
doi: 10.1016/j.jpain.2018.10.008
doi: 10.21115/JBES.v13.n3.p338-44
45. Rodríguez-Almagro D, López-Ruiz M, Cortés-Pérez I,
34. Muñoz R, Silva A, Dantas D, Fernandes A. Therapeutic Obrero-Gaitan E, Lomas-Veja R. Optimal dose and type of
itineraries of people with fibromyalgia to a pain treatment exercise to reduce pain, anxiety and increase quality of life in
center: A qualitative study. ABCS Health Sci. 2018;43(3):148- patients with fibromyalgia. A systematic review with meta-
155. analysis. Front Physiol. 2023;14:1170621.
doi: 10.7322/abcshs.v43i3.1087 doi: 10.3389/fphys.2023.1170621
35. Schaefer C, Adams E, Udall M, et al. Fibromyalgia outcomes 46. Mascarenhas R, Souza M, Oliveira M, et al. Association of
over time: Results from a prospective observational study in therapies with reduced pain and improved quality of life in
the United States. Open Rheumatol J. 2016;10:109-121. patients with fibromyalgia: A systematic review and meta-
doi: 10.2174/1874312901610010109 analysis. JAMA Intern Med. 2021;181(1):104-112.
36. Fernandes R, Morais N, Viebig RF, Morimoto JM. doi: 10.1001/JAMAINTERNMED.2020.5651
Relationship between sleep disorders and fibromyalgia 47. Ghavidel-Parsa B, Bidari A, Maafi A, Ghalebaghi B. The
severity: the impact on quality of life of Brazilian users of Iceberg nature of fibromyalgia burden: The clinical and
social networks. Rev Bras Qual Vida. 2020;12(1). economic aspects. Korean J Pain. 2015;28(3):169-176.
doi: 10.3895/rbqv.v12n1.10150 doi: 10.3344/kjp.2015.28.3.169
37. Gerdle B, Ghafouri B, Ernberg M, Larsson B. Chronic 48. Borsook D, Youssef AM, Simons L, Elman I, Eccleston C.
musculoskeletal pain: Review of mechanisms and When pain gets stuck: The evolution of pain chronification
biochemical biomarkers as assessed by the microdialysis and treatment resistance. Pain. 2018;159(12):2421-2436.
technique. J Pain Res. 2014;7:313-326.
doi: 10.1097/j.pain.0000000000001401
doi: 10.2147/JPR.S59144
49. Bergsten L, Lundberg M, Lindberg P, Elfving B. Change in
38. Häuser W, Fitzcharles MA. Facts and myths pertaining to kinesiophobia and its relation to activity limitation after
fibromyalgia. Dialogues Clin Neurosci. 2018;20(1):53-62. multidisciplinary rehabilitation in patients with chronic
doi: 10.31887/DCNS.2018.20.1/whauser back pain. Disabil Rehabil. 2012;34(10):852-858.
39. Martínez-Lavín M. Fibromyalgia and small fiber neuropathy: doi: 10.3109/09638288.2011.624247
The plot thickens! Clin Rheumatol. 2018;37(12):3167-3171.
50. Vlaeyen J, Linton S. Fear-avoidance model of chronic
doi: 10.1007/s10067-018-4300-2 musculoskeletal pain: 12 years on. Pain. 2012;153(6):
1144-1147.
40. Nijs J, Leysen L, Adriaenssens N, et al. Pain following
cancer treatment: Guidelines for the clinical classification doi: 10.1016/j.pain.2011.12.009
Volume 11 Issue 5 (2025) 77 doi: 10.36922/JCTR025290042

